Roivant Sciences (ROIV) Current Deferred Revenue: 2021-2025

Historic Current Deferred Revenue for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $1.2 million.

  • Roivant Sciences' Current Deferred Revenue fell 71.98% to $1.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.2 million, marking a year-over-year decrease of 71.98%. This contributed to the annual value of $1.2 million for FY2025, which is 71.98% down from last year.
  • Per Roivant Sciences' latest filing, its Current Deferred Revenue stood at $1.2 million for FY2025, which was down 61.54% from $3.0 million recorded in FY2024.
  • Over the past 5 years, Roivant Sciences' Current Deferred Revenue peaked at $12.4 million during FY2023, and registered a low of $1.2 million during FY2025.
  • In the last 3 years, Roivant Sciences' Current Deferred Revenue had a median value of $4.2 million in 2024 and averaged $5.1 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 71.46% in 2022, then plummeted by 71.98% in 2025.
  • Yearly analysis of 5 years shows Roivant Sciences' Current Deferred Revenue stood at $5.9 million in 2021, then skyrocketed by 71.46% to $10.1 million in 2022, then reached $7.8 million in 2022, then grew by 22.64% to $12.4 million in 2023, then crashed by 39.78% to $4.7 million in 2023, then crashed by 66.51% to $4.2 million in 2024, then plummeted by 35.31% to $3.0 million in 2024, then tumbled by 71.98% to $1.2 million in 2025.